Skip to content
10-Q

Quarterly Report

NANOVIRICIDES, INC. NNVC

0001410578-25-000140

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Feb 14, 2025 15.64M sh
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.96M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $4.8M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.18M
Current Liabilities Q2 2025 · Jun 30, 2024 $1.36M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.2M
Current Assets Q2 2025 · Dec 31, 2024 $4.07M
Current Assets Q2 2025 · Jun 30, 2024 $4.97M
Total Assets Q2 2025 · Dec 31, 2024 $11.57M
Total Assets Q2 2025 · Jun 30, 2024 $12.82M
Shares Diluted Q2 2025 · Dec 31, 2023 11.75M sh
Shares Diluted Q2 2025 · Dec 31, 2023 11.73M sh
Capex Q2 2025 · Dec 31, 2023 $13.77K
Operating Cash Flow Q2 2025 · Dec 31, 2023 −$2.89M
Stockholders Equity Q2 2025 · Dec 31, 2023 $12.45M
Stockholders Equity Q2 2025 · Sep 30, 2023 $12.97M
Stockholders Equity Q2 2025 · Jun 30, 2023 $14.87M
Eps Diluted Q2 2025 · Dec 31, 2023 −$0.18
Eps Diluted Q2 2025 · Dec 31, 2023 −$0.35
Eps Basic Q2 2025 · Dec 31, 2023 −$0.18
Eps Basic Q2 2025 · Dec 31, 2023 −$0.35
Sga Expense Q2 2025 · Dec 31, 2023 $610.88K
Sga Expense Q2 2025 · Dec 31, 2023 $1.18M
Rd Expense Q2 2025 · Dec 31, 2023 $1.57M
Rd Expense Q2 2025 · Dec 31, 2023 $3.04M
Net Income Q2 2025 · Dec 31, 2023 −$2.11M
Net Income Q2 2025 · Dec 31, 2023 −$4.08M
Net Income Q2 2025 · Sep 30, 2023 −$1.97M
Operating Income Q2 2025 · Dec 31, 2023 −$2.18M
Operating Income Q2 2025 · Dec 31, 2023 −$4.22M